ELISA.

RC Romain Deshayes de Cambronne
AF Agnès Fouet
AP Amandine Picart
AB Anne-Sophie Bourrel
CA Cyril Anjou
GB Guillaume Bouvier
CC Cristina Candeias
AB Abdelouhab Bouaboud
LC Lionel Costa
AB Anne-Cécile Boulay
MC Martine Cohen-Salmon
IP Isabelle Plu
CR Caroline Rambaud
EF Eva Faurobert
CA Corinne Albigès-Rizo
AT Asmaa Tazi
CP Claire Poyart
JG Julie Guignot
request Request a Protocol
ask Ask a question
Favorite

To evaluate integrin or ICAM1 binding to immobilized BRSrr2 or BRSrr1 regions, ELISA assays were performed as follows: proteins were coated at 5 μg/mL overnight. After extensive wash and saturation with BSA (Probumin, MilliporeSigma), 50 μL of ligand proteins (human integrins, ICAM1, or negative control BSA) were diluted at the specified concentrations in PBS containing 1% BSA (Probumin) and incubated 2 hours at 37°C. Integrin binding was assessed using antibodies listed in Supplemental Table 4. Binding was detected using o-phenylenediamine dihydrochloride (OPD) (Sigma-Aldrich) or 3,3′,5,5′-tetramethylbenzidine (TMB) (Thermo Fisher Scientific). Values of the negative control obtained with BSA (Probumin) were subtracted from the signal. The effect of divalent cations on the interaction between BRSrr2 and integrins was tested by ELISA with the same protocol as above in the presence of 1 mM Mn2+ or 1 mM Ca2+, as specified. Similarly, competition experiments were carried out by incubating 10 μg of integrins with immobilized BRSrr2 in the presence of increasing concentrations of mimetic peptides (RGDS, RGDfV, or P11).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A